[HTML][HTML] Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Y Chen, X Zhao, H Zhou, H Zhu, S Jiang… - Nature Reviews …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

[HTML][HTML] Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter

…, Z Fu, X Qu, P Wang, J Deng, X Yang, J Wang, H Zhu - Molecular Therapy, 2016 - cell.com
HIV-1 escapes antiretroviral agents by integrating into the host DNA and forming a latent
transcriptionally silent HIV-1 provirus. Transcriptional activation is prerequisite for reactivation …

Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells

…, S Liu, L Liu, J Wang, F Zhang, D Lu, H Zhu - Nucleic acids …, 2013 - academic.oup.com
HIV-infected individuals currently cannot be completely cured because existing antiviral
therapy regimens do not address HIV provirus DNA, flanked by long terminal repeats (LTRs), …

Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis

H Zhu, Y Wang, J Chen, G Cheng, J Xue - Experimental and molecular …, 2004 - Elsevier
The hepatitis B virus X (HBx) protein is thought to be implicated in the development of
human hepatocellular carcinoma (HCC), but its exact function remains controversial. To …

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

X Wang, X Zhao, J Song, J Wu, Y Zhu, M Li… - Emerging microbes & …, 2022 - Taylor & Francis
The massive and rapid transmission of SARS-CoV-2 has led to the emergence of several
viral variants of concern (VOCs), with the most recent one, B.1.1.529 (Omicron), which …

[HTML][HTML] The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb

…, H Zeng, H Ji, J Deng, X Yang, X Li, H Lu, H Zhu - Scientific reports, 2016 - nature.com
None of the currently used anti-HIV-1 agents can effectively eliminate latent HIV-1 reservoirs,
which is a major hurdle to a complete cure for AIDS. We report here that a novel oral BET …

[HTML][HTML] Chemokine receptor CCR2b enhanced anti-tumor function of chimeric antigen receptor T cells targeting mesothelin in a non-small-cell lung carcinoma model

…, Z Jiang, X Shen, Z Liang, Y Liang, H Zhu - Frontiers in …, 2021 - frontiersin.org
Chimeric antigen receptor (CAR) T cell therapy faces a number of challenges for the treatment
of non-small-cell lung carcinoma (NSCLC), and efficient migration of circulating CAR T …

[HTML][HTML] BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency

…, Z Jiang, X Yang, Y Zhong, H Pan, J Xu, H Lu, H Zhu - Scientific Reports, 2017 - nature.com
Persistent latent reservoir in resting CD4+ T cells is a major obstacle in curing HIV-1 infection.
Effective strategies for eradication of the HIV-1 reservoir are urgently needed. We report …

[HTML][HTML] Reactivation of HIV-1 from latency by an ingenol derivative from Euphorbia kansui

…, X Zhu, Y Zhu, X Li, H Wu, J Xu, H Lu, Z Ma, H Zhu - Scientific reports, 2017 - nature.com
Cells harboring latent HIV-1 pose a major obstacle to eradication of the virus. The ‘shock and
kill’strategy has been broadly explored to purge the latent reservoir; however, none of the …

PEBP 1 suppresses HIV transcription and induces latency by inactivating MAPK/NF‐κB signaling

X Yang, Y Wang, P Lu, Y Shen, X Zhao, Y Zhu… - EMBO …, 2020 - embopress.org
The latent HIV ‐1 reservoir is a major barrier to viral eradication. However, our understanding
of how HIV ‐1 establishes latency is incomplete. Here, by performing a genome‐wide …